{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-005339","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2023-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.408128+00:00","generated_at":"2026-06-17T07:27:35.881000+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Bio-Techne completes $257M investment for 20% stake in Wilson Wolf; future buyout potential $1B","bullets":["$257M investment gives Bio-Techne 20% ownership of Wilson Wolf Manufacturing.","Investment triggered by Wilson Wolf achieving $55M trailing twelve-month EBITDA.","Bio-Techne has right to acquire remaining 80% for $1B if Wilson Wolf reaches $226M revenue or $136M EBITDA.","If milestone not met by Dec 31, 2027, acquisition price ~4.4x trailing twelve-month revenue.","Wilson Wolf develops G-Rex cell production technology for cell and gene therapy; used by over 800 CGT market participants."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-005339","json":"https://secwatch.observer/filing/0001558370-23-005339.json","markdown":"https://secwatch.observer/filing/0001558370-23-005339.md","text":"https://secwatch.observer/filing/0001558370-23-005339.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000155837023005339/0001558370-23-005339-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000155837023005339/tmb-20230331x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T07:27:35.881000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}